This was part of
Decision Making in Health and Medical Care
Medical treatments for rare diseases: my FDA perspective
Ilan Irony, FDA/CBER
Monday, May 17, 2021
Abstract: Dr. Irony will present on the topic of FDA engagement in assisting the development of treatments for rare diseases, through the use of various regulatory authorities available.